Citations (24)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Filip Jansåker, Niels Frimodt-Møller, Thomas L Benfield & Jenny Dahl Knudsen. (2018) Mecillinam for the treatment of acute pyelonephritis and bacteremia caused by Enterobacteriaceae: a literature review. Infection and Drug Resistance 11, pages 761-771.
Read now
Read now
Noha El Sakka & Ian M. Gould. (2016) Role of old antimicrobial agents in the management of urinary tract infection. Expert Review of Clinical Pharmacology 9:8, pages 1047-1056.
Read now
Read now
Johann D Pitout, Wilson W Chan & Deirdre L Church. (2016) Tackling antimicrobial resistance in lower urinary tract infections: treatment options. Expert Review of Anti-infective Therapy 14:7, pages 621-632.
Read now
Read now
Articles from other publishers (21)
André Birgy, Fouad Madhi, Camille Jung, Corinne Levy, Aurélie Cointe, Philippe Bidet, Claire Amaris Hobson, Stéphane Bechet, Elsa Sobral, Hoang Vuthien, Agnès Ferroni, Saïd Aberrane, Gaëlle Cuzon, Laetitia Beraud, Vincent Gajdos, Elise Launay, Didier Pinquier, Hervé Haas, Marie Desmarest, Marie-Aliette Dommergues, Robert Cohen, Stéphane Bonacorsi, Marie-Noëlle Adam, Marleèe Amara, Isabelle Andriantahina, Abdelmalek Belgaid, Sandra Biscardi, Sophie Boyer, Catherine Branger, Isabelle Breant, Jack Breuil, Jocelyne Caillon, Emmanuel Cixous, Bogdan Cojocaru, Irina Craiu, Marion Decobert, Rodrigue Dessein, Florence Doucet-Populaire, François Dubos, Sarah Ducrocq, Anne Farges-Berth, Cécile Farrugia, Alain Fiacre, Aurélien Galerne, Hélène Garrec, Emilie Georget, Emmanuel Grimprel, Laure Hees, Franck Labbee, Aurélia Pitsch, Isabelle Poilane, Valérie Sivadon-Tardy, Valérie Soussan-Banini, Benoit Starck, Sandra Timsit, Philippe Traore, Anne Vachee & Olivier Vignaud. (2021)
Clavulanate combinations with mecillinam, cefixime or cefpodoxime against ESBL-producing Enterobacterales frequently associated with
bla
OXA-1 in a paediatric population with febrile urinary tract infections
. Journal of Antimicrobial Chemotherapy 76:11, pages 2839-2846.
Crossref
Crossref
Maroun M. Sfeir, Gulce Askin & Paul Christos. (2018) Beta-lactam/beta-lactamase inhibitors versus carbapenem for bloodstream infections due to extended-spectrum beta-lactamase-producing Enterobacteriaceae: systematic review and meta-analysis. International Journal of Antimicrobial Agents 52:5, pages 554-570.
Crossref
Crossref
Marianne Bollestad, Nils Grude, Sigrid Solhaug, Niclas Raffelsberger, Nina Handal, Hans-Johnny Schjelderup Nilsen, Monica Regine Romstad, Andreas Emmert, Yngvar Tveten, Arne Søraas, Pål A Jenum, Synne Jenum, Janne Møller-Stray, Einar Tollaksen Weme, Morten Lindbaek & Gunnar Skov Simonsen. (2018) Clinical and bacteriological efficacy of pivmecillinam treatment for uncomplicated urinary tract infections caused by ESBL-producing Escherichia coli: a prospective, multicentre, observational cohort study. Journal of Antimicrobial Chemotherapy 73:9, pages 2503-2509.
Crossref
Crossref
André Birgy, Marine Delecourt, Guillaume Geslain, Emilie Desselas, Marion Caseris, Mélanie Magnan, Patricia Mariani-Kurkdjian, Philippe Bidet & Stéphane Bonacorsi. (2017) A combination of mecillinam and amoxicillin/clavulanate can restore susceptibility of high-level TEM-1-producing Escherichia coli to mecillinam. Journal of Antimicrobial Chemotherapy 72:7, pages 1911-1914.
Crossref
Crossref
C. Duployez, C. Loiez, C. Cattoen, D. Descamps, F. Wallet & A. Vachée. (2016) In vitro susceptibility to mecillinam of Escherichia coli strains isolated from the urine of pregnant women. Médecine et Maladies Infectieuses 46:8, pages 436-441.
Crossref
Crossref
Elisa Vidal, Carlos Cervera, Elisa Cordero, Carlos Armiñanzas, Jordi Carratalá, José Miguel Cisneros, M. Carmen Fariñas, Francisco López-Medrano, Asunción Moreno, Patricia Muñoz, Julia Origüen, Núria Sabé, Maricela Valerio & Julián Torre-Cisneros. (2015) Management of urinary tract infection in solid organ transplant recipients: Consensus statement of the Group for the Study of Infection in Transplant Recipients (GESITRA) of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) and the Spanish Network for Research in Infectious Diseases (REIPI). Enfermedades Infecciosas y Microbiología Clínica 33:10, pages 679.e1-679.e21.
Crossref
Crossref
N. T. Mutters, S. Zimmermann, M. Kaase & A. Mischnik. (2015) Activity of temocillin, mecillinam, ceftazidime, and ceftazidime/avibactam against carbapenem-non-susceptible Enterobacteriaceae without carbapenemase production. European Journal of Clinical Microbiology & Infectious Diseases 34:12, pages 2429-2437.
Crossref
Crossref
F Jansaker. (2015) Pivmecillinam Treatment of Community-Acquired Uncomplicated Pyelonephritis Based on Sparse Data. Global Journal of Infectious Diseases and Clinical Research, pages 014-017.
Crossref
Crossref
Nadim Cassir, Jean-Marc Rolain & Philippe Brouqui. (2014) A new strategy to fight antimicrobial resistance: the revival of old antibiotics. Frontiers in Microbiology 5.
Crossref
Crossref
S. Dewar, L. C. Reed & R. J. Koerner. (2013) Emerging clinical role of pivmecillinam in the treatment of urinary tract infection in the context of multidrug-resistant bacteria. Journal of Antimicrobial Chemotherapy 69:2, pages 303-308.
Crossref
Crossref
Arne Søraas, Arnfinn Sundsfjord, Silje Bakken Jørgensen, Knut Liestøl & Pål A. Jenum. (2014) High Rate of Per Oral Mecillinam Treatment Failure in Community-Acquired Urinary Tract Infections Caused by ESBL-Producing Escherichia coli. PLoS ONE 9:1, pages e85889.
Crossref
Crossref
Mercedes Delgado-Valverde, Jesús Sojo-Dorado, Álvaro Pascual & Jesús Rodríguez-Baño. (2013)
Clinical management of infections caused by multidrug-resistant
Enterobacteriaceae
. Therapeutic Advances in Infectious Disease 1:2, pages 49-69.
Crossref
Crossref
N. Lampri, I. Galani, G. Poulakou, I. Katsarolis, G. Petrikkos, H. Giamarellou & M. Souli. (2012) Mecillinam/clavulanate combination: a possible option for the treatment of community-acquired uncomplicated urinary tract infections caused by extended-spectrum -lactamase-producing Escherichia coli. Journal of Antimicrobial Chemotherapy 67:10, pages 2424-2428.
Crossref
Crossref
Emilia TitelmanAina IversenMats KalinChristian G. Giske. (2012)
Efficacy of Pivmecillinam for Treatment of Lower Urinary Tract Infection Caused by Extended-Spectrum β-Lactamase–Producing
Escherichia coli
and
Klebsiella pneumoniae
. Microbial Drug Resistance 18:2, pages 189-192.
Crossref
Crossref
M. Tärnberg, Å. Östholm-Balkhed, H.-J. Monstein, A. Hällgren, H. Hanberger & L. E. Nilsson. (2011) In vitro activity of beta-lactam antibiotics against CTX-M-producing Escherichia coli. European Journal of Clinical Microbiology & Infectious Diseases 30:8, pages 981-987.
Crossref
Crossref
Souha S. Kanj & Zeina A. Kanafani. (2011) Current Concepts in Antimicrobial Therapy Against Resistant Gram-Negative Organisms: Extended-Spectrum β-Lactamase–Producing Enterobacteriaceae, Carbapenem-Resistant Enterobacteriaceae, and Multidrug-Resistant Pseudomonas aeruginosa. Mayo Clinic Proceedings 86:3, pages 250-259.
Crossref
Crossref
Simon Auer, Alexandra Wojna & Markus Hell. (2010)
Oral Treatment Options for Ambulatory Patients with Urinary Tract Infections Caused by Extended-Spectrum-β-Lactamase-Producing
Escherichia coli
. Antimicrobial Agents and Chemotherapy 54:9, pages 4006-4008.
Crossref
Crossref
Zefiryn Cybulski & Poul Kjaeldgaard. (2010) Resistance to oral antibiotics in urinary coliform strains isolated between 2000 and 2008 in Sønderborg area, Denmark. International Journal of Antimicrobial Agents 35:5, pages 516-517.
Crossref
Crossref
Johann D.D. Pitout. (2010) Infections with Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae. Drugs 70:3, pages 313-333.
Crossref
Crossref
Matthew E Falagas, Antonia C Kastoris, Anastasios M Kapaskelis & Drosos E Karageorgopoulos. (2010) Fosfomycin for the treatment of multidrug-resistant, including extended-spectrum β-lactamase producing, Enterobacteriaceae infections: a systematic review. The Lancet Infectious Diseases 10:1, pages 43-50.
Crossref
Crossref
Chang-Ki KimJong Hwa YumSang-Guk LeeYangsoon LeeJun Yong ChoiJune Myung KimKyungwon LeeYunsop Chong. (2009) In vitro Activities of Mecillinam Against Clinical Isolates of Enterobacteriaceae. Infection and Chemotherapy 41:3, pages 174.
Crossref
Crossref